Mega Deals

Luxfer Enters Into Agreement to Be Acquired for $17.37 Per Share in All-Cash Transaction – Business Wire

Luxfer Enters Into pact to Be bought for $17.37 Per Share in All-Cash Transaction Business Wire Source: news.google.com

TransDigm Announces Acquisition of Prince & Izant – PR Newswire

TransDigm Announces buyout of Prince & Izant PR Newswire Source: news.google.com

Yarrow Bioscience Announces Closing of Merger with VYNE Therapeutics and Initiation of Dosing in Phase 2a/2b Trial of YB-101, a Potential First-in-Class Treatment for Graves’ Disease and Thyroid Eye Disease – Business Wire

Yarrow Bioscience Announces Closing of combination with VYNE Therapeutics and Initiation of Dosing in Phase 2a/2b Trial of YB-101, a Potential First-in-Class Treatment for Graves’ Disease and Thyroid Eye Disease Business Wire Source: news.google.com

Mega Deals

Vireo Growth Inc. to Acquire Planet 13 Holdings Inc. – GlobeNewswire

Vireo Growth Inc. to buy Planet 13 Holdings Inc. GlobeNewswire Source: news.google.com

Mega Deals

Irish Continental shares jump on $1.37 billion management-led buyout – Reuters

Irish Continental shares jump on $1.37 billion management-led buyout Reuters Source: news.google.com

Mega Deals

argenx to Acquire Forte Biosciences, Inc., Adding First-in-Class Anti-CD122 Antibody, FB102, to Its Immunology Pipeline – Business Wire

argenx to buy Forte Biosciences, Inc., Adding First-in-Class Anti-CD122 Antibody, FB102, to Its Immunology Pipeline Business Wire Source: news.google.com

Mega Deals

argenx to Acquire Forte Biosciences, Inc., Adding First-in-Class anti-CD122 Antibody, FB102, to its Immunology Pipeline – GlobeNewswire

argenx to buy Forte Biosciences, Inc., Adding First-in-Class anti-CD122 Antibody, FB102, to its Immunology Pipeline GlobeNewswire Source: news.google.com

Mega Deals

Mega Deals

TransDigm Announces Acquisition of Prince & Izant – PR Newswire

Yarrow Bioscience Announces Closing of Merger with VYNE Therapeutics and Initiation of Dosing in Phase 2a/2b Trial of YB-101, a Potential First-in-Class Treatment for Graves’ Disease and Thyroid Eye Disease – Business Wire

Vireo Growth Inc. to Acquire Planet 13 Holdings Inc. – GlobeNewswire

Irish Continental shares jump on $1.37 billion management-led buyout – Reuters

argenx to Acquire Forte Biosciences, Inc., Adding First-in-Class Anti-CD122 Antibody, FB102, to Its Immunology Pipeline – Business Wire

argenx to Acquire Forte Biosciences, Inc., Adding First-in-Class anti-CD122 Antibody, FB102, to its Immunology Pipeline – GlobeNewswire

Aktsiaselts Infortar own share acquisition transactions – GlobeNewswire

White Sox acquire RHP Jose Urquidy in trade with Pirates – Reuters

Brewers DFA recently acquired Lance McCullers Jr. – Reuters

Sign up to receive email updates, fresh news and more!